VY1706, an IV-delivered tau silencing gene therapy that has shown up to 73% knockdown of tau mRNA in non-human primates following a single IV dose and is advancing towards IND in 2026.

The deal will see Apple and MP Materials launch a recycling facility for processing recycled rare earth elements. Once ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

The selection of a first-line treatment for patients with advanced EGFR -positive non-small cell lung cancer (NSCLC) has ...

Dizal will market sunvozertinib in the US under the Zegfrovy brand name, entering a market for EGFR inhibitors currently dominated by AstraZeneca's Tagrisso (osimertinib) but currently being shaken up ...

Nigerians awaiting their second dose of the Oxford/AstraZeneca vaccine can sigh of relief as the government on 17 August 2021 received additional 699,760 doses in Abuja.

Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health ...

During the AstraZeneca-Oxford trial, some human participants erroneously received a half dose of their first shot, followed by a full dose for their second shot.

The study confirmed an elevated risk of rare blood clotting after the first dose, though experts stress this is small compared to the risk of Covid-19.

AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker ...

How long after should I receive my second dose? The recommended time interval for receiving the second dose of AstraZeneca vaccine is 12 weeks or at least four weeks.